ISB News

Biomedical Pioneer: Dr. Leroy Hood

Dr. Leroy Hood, ISB's president and co-founder, was featured in this Q&A in Medgadget:

"If you are involved in biomedical research you have almost certainly used a device or technique developed by Leroy Hood. The most notable among his innovations include the automated DNA sequencer and synthesizer as well as the automated protein sequencer and synthesizer. For his work on these four instruments – cornerstones of modern molecular biology – Dr. Hood was awarded the American and Japanese equivalents of the Nobel Prize: the Lasker Award and Kyoto Prize. Throughout his career he has successfully translated his basic science research from bench-to-bedside by co-founding more than 14 companies, including Amgen and Applied Biosystems."

Recent Articles

  • Understanding, Preventing and Treating Long-Term Effects of COVID: RECOVER Study Enrolling Patients from Pacific Northwest

    As part of a massive nationwide effort, ISB is leading a multi-site consortium for the NIH RECOVER (Researching COVID to Enhance Recovery) Initiative. The Pacific Northwest consortium is made up of ISB, Providence, Swedish, and University of Washington School of Medicine.

  • Spotlight on ISB Education graphic

    2021-22 School Year ISB Education Highlights

    From planning, creating and executing workshops for educators to forging new relationships to elevate students, the ISB Education team has been in high gear. Each month throughout the 2021-2022 academic year, we will highlight some of the top projects the team is working on.

  • Jim Heath AACR Academy Fellow

    Dr. Jim Heath Named Fellow of AACR Academy Class of 2022

    Dr. Jim Heath was announced as a newly elected Fellow of the American Academy for Cancer Research (AACR) Academy Class of 2022. “I am honored and humbled to be recognized as part of this renowned group of researchers who have done so much to move our understanding of cancer forward,” Heath said.